A CT-based Radiomics Model to Predict Survival-graded Fibrosis in PDAC

CompletedOBSERVATIONAL

Enrollment

295

Participants

Timeline

Start Date

January 13, 2021

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2023

Conditions

Pancreatic Cancer

Interventions

PROCEDURE

surgery

Patients with suspected pancreatic cancer who underwent contrast-enhanced CT and pathological examinations after the surgery.

Trial Locations (1)

Shi Siya, Guangzhou

All Listed Sponsors

lead

First Affiliated Hospital, Sun Yat-Sen University

OTHER

NCT06267690 - A CT-based Radiomics Model to Predict Survival-graded Fibrosis in PDAC | Biotech Hunter | Biotech Hunter